all report title image

RED BIOTECHNOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial Biotechnology, Agricultural Biotechnology, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : Nov 2023
  • Code : CMI6416
  • Pages :150
  • Formats :
      Excel and PDF
  • Industry : Biotechnology
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet , By End User
      • Market Snippet , By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Increasing prevalence of chronic diseases
      • Pricing pressures on biologics
      • Biotech applications in agriculture
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Red Biotechnology Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Red Biotechnology Market, By Product Type, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Biopharmaceuticals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Biosimilars
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Gene Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Tissue Engineering
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  6. Global Red Biotechnology Market, By Application, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Drug Discovery & Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Animal Biotechnology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Environmental Biotechnology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Medical Biotechnology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Industrial Biotechnology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Agricultural Biotechnology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  7. Global Red Biotechnology Market, By End User, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Pharmaceutical & Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Biotechnology Industry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Hospitals & Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Academic Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  8. Global Red Biotechnology Market, By Region, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Region, 2019-2030
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape
    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Gilead Sciences, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Biogen
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co. Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GSK plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novo Nordisk A/S
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Astellas Pharma Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  10. Section
    • Research Methodology
    • About us

*Browse 25 market data tables and 39 figures on “Global Red Biotechnology Market” - Global forecast to 2030

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.